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Abstract
Dogs are the domestic reservoirs of zoonotic visceral leishmaniasis caused by Leishmania
infantum. Early detection of canine infections evolving to clinically patent disease may be
important to leishmaniasis control. In this study we firstly investigated the peripheral blood
mononuclear cell (PBMC) response to leishmanial antigens and to polyclonal activators
concanavalin A, phytohemagglutinin and pokeweed mitogen, of mixed-breed dogs with natural
L. infantum infection, either in presymptomatic or in patent disease condition, compared to healthy
animals. Leishmania antigens did not induce a clear proliferative response in any of the animals
examined. Furthermore, mitogen-induced lymphocyte proliferation was found strongly reduced not
only in symptomatic, but also in presymptomatic dogs suggesting that the cell-mediated immunity
is suppressed in progressive canine leishmaniasis. To test this finding, naive Beagle dogs were
exposed to natural L. infantum infection in a highly endemic area of southern Italy. Two to 10
months after exposure all dogs were found to be infected by Leishmania, and on month 2 of
exposure they all showed a significant reduction in PBMC activation by mitogens. Our results
indicate that suppression of the lymphoproliferative response is a common occurrence in dogs
already at the beginning of an established leishmanial infection.# 1999 Elsevier Science B.V. All
rights reserved.
Keywords: Dog; Leishmaniasis; Leishmania infantum; Lymphocyte proliferation
Veterinary Immunology and Immunopathology
70 (1999) 95–103
* Corresponding author. Tel.: +39-06-4990-2309; fax: +39-06-4938-7065
E-mail address: gradoni@iss.it (L. Gradoni)
0165-2427/99/$ – see front matter # 1999 Elsevier Science B.V. All rights reserved.
PII: S 0 1 6 5 - 2 4 2 7 ( 9 9 ) 0 0 0 7 3 - 2
1. Introduction
Dogs are the domestic reservoirs of Leishmania infantum, the agent of zoonotic
visceral leishmaniasis in the Mediterranean Basin (World Health Organization, 1991).
These animals may develop a severe syndrome characterized by chronic evolution of
viscerocutaneous signs which result from Leishmania multiplication in macrophages of
spleen, liver, bone marrow, lymph nodes and skin. After an incubation period of 1
month to several years (Keenan et al., 1984), symptoms appear with weakness,
weight loss, diffuse dermatitis, splenomegaly, lymph node enlargement, anemia and
renal failure. At this stage, the disease is refractory to conventional drugs successfully
used in human therapy. Cross-sectional studies carried out in natural disease foci
have shown that only about 50% of the infected dogs display viscerocutaneous
involvement, while the remaining animals have no specific signs (Lanotte et al.,
1979; Pozio et al., 1981). These asymptomatic dogs have antileishmanial serum
antibodies and can be positive to parasite isolation. As suggested by longitudinal
studies, asymptomatic cases may represent resistant dogs which can control or even
eliminate the parasite, or susceptible presymptomatic dogs which tend to evolve
toward patency within a variable period of time (Pozio et al., 1981). Discrimination
between these subgroups of animals could be epidemiologically important, since
symptoms tend to be associated with higher infectivity to phlebotomine vectors
(Gradoni et al., 1987).
The aim of this study was to evaluate leishmanial antigen- and mitogen-induced
lymphoproliferative response in naturally infected asymptomatic preclinical dogs, and
to confirm our results in a cohort of naive Beagle dogs exposed to naturally transmitted
L. infantum. We employed lymphocyte proliferation assay (LPA) using crude
Leishmania soluble (LS) antigen as well as two recombinant leishmanial antigens for
the specific response to L. infantum, and the mitogens concanavalin A (Con A),
phytohemagglutinin (PHA) and pokeweed mitogen (PWM) for T and B cell polyclonal
activation.
2. Materials and methods
2.1. Leishmania serology and parasitology
Serum samples were examined by immunofluorescence antibody test using L. infantum
promastigotes as antigen and a serum dilution of 1 : 40 as threshold titre (Pozio et al.,
1981). Sera were also examined by an ELISA test employing the recombinant
leishmanial antigen K39 and recently developed as diagnostic kit for canine leishmaniasis
(Gradoni et al., 1997). Sera showing absorbance value 0.4 were considered positive.
Lymph node and/or bone marrow aspirate samples were partly smeared on slides and
stained with Giemsa’s stain for micoscopical examination, and partly seeded into Evans’
modified Tobie’s medium (biphasic) and ‘sloppy’ Evans medium (semi-solid) (Evans,
1987).
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2.2. Dogs
In the first part of the study, three groups of mixed-breed, adult dogs of both sexes from
the Naples area of Italy were used. The first group (controls) consisted of 10 healthy
animals with no Leishmania on clinical, serological and parasitological examinations.
The second group, hereafter designated as presymptomatic dogs, consisted of seven
naturally infected animals diagnosed as having leishmaniasis by specific serology and
parasitology, but not showing any clinical evidence of the disease when this study was
performed. The dogs were housed thereafter in a kennel and followed up for several
months after diagnosis. They all developed a viscerocutaneous disease 8 to 10 months
later. The third group, designated as symptomatic dogs, consisted of 10 naturally infected
animals in a chronic stage of viscerocutaneous leishmaniasis, characterized by organic
alterations and by the most common clinical signs of the disease, such as systemic lymph
adenopathy, diffuse furfuraceous dermatitis/depilation and skin ulcers. For both groups of
infected dogs the duration of leishmaniasis was unknown.
In the second part of the study, five naive Beagles of both sexes (Stefano Morini,
Reggio Emilia, Italy), 2 to 4 years old, were housed together in a kennel in a highly
endemic area of canine leishmaniasis in southern Italy, during winter months. In this
region, the L. infantum transmission season (coinciding with the presence of biting
phlebotomine sandflies) lasts from late May to late September (Maroli et al., 1993). The
dogs were under constant veterinary control to exclude concomitant infections/diseases.
Specific serological and parasitological investigations for leishmaniasis were carried out
periodically before, during and up to 6 months after natural exposure. By the end of the
observation period all dogs showed evidence of an established Leishmania infection
(positive serology and parasitology), with no evidence of other infections/diseases.
Seroconversion and presence of Leishmania were shown in each animal at different
times: specific antibodies were firstly detected on late July in three dogs, whereas first
parasite demonstration was obtained on late October in two dogs. During the observation
period, only one dog evolved to a patent clinical condition.
2.3. Leishmanial antigens
LS antigen was obtained by freezing and thawing a suspension of washed L. infantum
promastigotes three times. The disrupted organisms were then centrifugated at 8000  g
for 30 min and the protein concentration of the resulting supernatant was adjusted at
1 mg/ml. Recombinant leishmanial antigens rLeIF and rLdp23 were a gift from Dr. S.
Reed, Corixa, Seattle, USA. They were shown to strongly stimulate cell-mediated
immune response in murine and human hosts (Skeiky et al., 1995; Campos-Neto et al.,
1995).
2.4. Lymphocyte proliferation assay
Peripheral blood mononuclear cells (PBMC) were isolated from heparinized blood by
centrifugation over Ficoll/Hypaque (density 1.077; Pharmacia, Uppsala, Sweden) for
30 min at 400  g at room temperature (Boyum, 1968). The mononuclear cell layer was
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collected, washed three times in Dulbecco’s phosphate buffered saline without calcium
and magnesium (PBS), and centrifuged for 15 min at 400  g. The pellet was
resuspended in RPMI 1640 medium supplemented with 10% fetal bovine serum,
50 mmg/ml gentamicin, 2 mM l-glutamine and 10ÿ5 M 2-mercaptoethanol, hereafter
designated complete medium. Mononuclear cell purity was 60–70%, as assessed by
Giemsa stain, and cell viability, checked with the trypan blue exclusion test, was greater
than 95%. The cell count was adjusted to 1.5  106 cells/ml.
LPA was performed using the [3H] thymidine uptake assay as described by Oppenheim
and Rosenstreich (1976) and Kristensen et al. (1982). Briefly, PBMC were cultured in
triplicate into 96-well flat-bottomed microtitre plates (Falcon plastics, Becton Dickinson
& Co., Oxnard, CA), in absence or in presence of antigens or mitogens. Optimal
stimulant concentrations and culture times were determined in preliminary kinetic
experiments. Each well contained 100 ml of cell suspension plus 100 ml of 20 mg/ml of
each antigen, or 4 mg/ml Con A (Sigma, Saint Louis, MO, USA), 2.5 mg/ml PHA
(Sigma), or 5 mg/ml PWM (Sigma) in complete medium. Cell cultures were incubated for
5 days (antigens) or 72 h (mitogens) in 90% relative humidity atmosphere, at 378C and
5% CO2. Cells were pulsed during the last 6 h of culture with 0.5 mCi of [
3H] thymidine
(5 Ci/mmol, Amersham, Buchs, UK) and were harvested on glass-wool filters. The [3H]
thymidine uptake was measured in a b liquid scintillation counter (LKB-Wallac, Turku,
Finland). Proliferative response was expressed as stimulation index (SI), representing the
ratio of counts per minute (cpm) of the mitogen-stimulated cultures to the cpm of control
cultures. A SI greater than 2.5 indicated a positive response (Cabral et al., 1998).
2.5. Data analysis
Differences in proliferative responses were analyzed for significance using the
Student’s t test.
3. Results
3.1. LPA in mixed-breed dogs
The crude LS antigen did not induce any specific response in either group of infected
dogs, whereas the recombinant antigens elicited only a moderate proliferative response in
presymptomatic animals, with a mean SI of 2.6–2.8 (Fig. 1).
The highest proliferative response to mitogens was obtained with Con A, whereas PHA
induced the lowest one. The mean SI values observed for the three groups after mitogen
stimulation are shown in Fig. 2. Nine out of 10 dogs from the control group showed high
SI values ranging 25.9–90.1 using Con A, 4.6–42.1 using PHA and 16.3–39.3 using
PWM. These parameters were much lower for one dog (7.3, 1.4 and 2.4 respectively).
Among the presymptomatic animals the SI values were also different and, on average,
significantly lower than those of normal dogs (ÿ62%, P < 0.05). Five out of seven
animals showed very low SI ranges (2.5ÿ5.1 with Con A, 0.6–4.5 with PHA and 1.5–5.8
with PWM), whereas in two dogs the response to mitogens was within the range recorded
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for responsive healthy animals. All the symptomatic dogs displayed a homogeneous
proliferative response which was very low compared to controls (ÿ93%), but not
significantly different from presymptomatic animals. The SI value range was 1.3–4.2
(Con A), 0.6–2.9 (PHA) and 0.7–4.2 (PWM).
Fig. 1. Lymphocyte proliferative response of PBMC from healthy (10), presymptomatic (7) and symptomatic
(10) dogs with leishmaniasis, after incubation with recombinant (rLeIF and rLdp23) and crude leishmanial
soluble (LSA) antigens. Data are presented as mean stimulation index + SEM.
Fig. 2. Lymphocyte proliferative response of PBMC from healthy (10), presymptomatic (7) and symptomatic
(10) dogs with leishmaniasis, after incubation with Con A, PWM and PHA. Data are presented as mean
stimulation index + SEM. Asterisks indicate significant differences between values for infected animals and
healthy controls (P < 0.05).
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3.2. LPA in naive Beagle dogs
LPA was performed with LS antigen as specific stimulator and Con A as mitogen, on
PBMC samples taken from Beagles before (March–April), and on month 2 of natural
exposure to Leishmania (late July). No further PBMC samples were available in the
follow-up period.
LS antigen stimulated no proliferative response in any dog before and during the
transmission period (Fig. 3(a)). When PBMC from dogs before Leishmania exposure
Fig. 3. Lymphocyte proliferative response of PBMC obtained from five Beagle dogs before (‘naive’) and after
exposure to natural L. infantum transmission (‘exposed’). (a) Mean stimulation index (+ SEM) after incubation
with leishmanial soluble (LS) antigen and Con A. Asterisk indicates significant difference between values
for naive and exposed dogs (P < 0.05). (b) Stimulation index for samples from each dog after incubation with
Con A.
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were cultured in presence of Con A, the SI values were as high as those recorded in
normal mixed-breed dogs (mean 35.3, range 21.0–70.0). These values were much lower
in LPA experiments performed on samples taken after 2 months of exposure (ÿ89%,
P < 0.05), for a mean SI value of 3.8. This sharp decrease in proliferative response was
observed in each dog, irrespectively of seroconversion time, Leishmania demonstration or
appearance of symptoms. Two dogs resulted unresponsive (SI < 2.5) (Fig. 3(b)).
4. Discussion
Most investigations on the canine response to natural and experimental leishmaniasis
have focused on the role of humoral and cell-mediated immunity. There is now evidence
that clinically patent Leishmania infection is associated with cytokine-mediated
impairement of T and B lymphocyte functions (Pinelli et al., 1994; Martinez-Moreno
et al., 1995).
Lymphocyte mitogenic stimulation by lectins provides an easy and simple mean to
assess the host immunocompetence in a number of diseases. The mitogens employed in
our study are classical polyclonal activators – Con A and PHA stimulate T cells, while
PWM stimulates both T and B cells – irrespectively of their antigenic specificity and can
be used to evaluate the functional status of lymphocyte populations. However, it is well
known that these mitogens require more than one cell type, particularly the presence of
macrophages and their cytokines, as well as cell–cell cooperation.
Our study has indicated significant immunological differences between healthy and
‘‘apparently healthy’’ (but presymptomatic) mixed-breed dogs with leishmaniasis, since
cell proliferation to various mitogens was found significantly lower in the latter group.
Because the natural history of the infection in these animals was unknown, it could not be
excluded that the immunosuppression was the result of a prolonged latent infection, as in
other parasitological disorders with chronic features (Cetron et al., 1993). However, our
findings on Leishmania-exposed naive dogs strongly suggest that suppression of
lymphoproliferative response may occur very early as a consequence of an established
Leishmania infection. This may be substantiated by the following points: first, since they
were living in the same environment the dogs were probably all infected during the first
period of exposure, as indicated by early seroconversions; second, after 2 months of
exposure the animals showed equally profound depression in cellular immune response;
third, by the end of the observation period, a leishmanial infection was demonstrated in
all dogs; and fourth, on the basis of clinical and laboratory monitoring it was excluded
that immunological changes were related to other concomitant infections/diseases.
Few studies have been carried out on lymphoproliferative response to mitogens in dogs
experimentally or naturally infected by L. infantum, with different results. In the study of
Pinelli et al. (1994) on Spanish dogs, symptomatic animals showed a mitogenic
proliferative response similar to uninfected control dogs. Although the lymphoprolifera-
tive assay employed by these authors was basically the same we used, the study
population was different in part. Three out of six symptomatic dogs examined consisted
of naive Beagles that had been experimentally infected with a single Leishmania dose and
that slowly evolved to a patent clinical condition. In our study, naive Beagles have been
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exposed to sandfly bites during 2 months, in a site where the force of leishmanial
infection is extremely high (Maroli et al., 1993). It is much probable, as it appears from
the 100% leishmaniasis incidence found in our dog cohort, that the animals received
multiple infective bites, and hence higher antigen doses and/or repeated T-cell stimulation
could have provoked rapid establishment of a marked Th2 profile (London et al., 1998),
revealed by profound depression in lymphoproliferative response. The different results of
ConA response in symptomatic, naturally infected mixed breed dogs of the Pinelli et al.
study are more difficult to explain. The three Spanish dogs examined exhibited a mean SI
value which was even higher than in healthy animals (269 versus 212, respectively),
whereas in our symptomatic mixed breed dogs this was, on average, about one tenth of
normal dogs. On the other hand, the Spanish dogs showed partial (1 animal) or full (2
animals) abrogation of IL-2 production. This observation is unclear and in contrast with
the general notion that IL-2 is the main cytokine controlling the proliferative response in
CD4 lymphocytes. It is also different from findings obtained in murine (Nickol and
Bonventre, 1985; Evans et al., 1990) and human (Barral et al., 1986) hosts, which
demonstrate that suppression of lymphocyte proliferation is a major immunopathological
consequence of infection with a viscerotropic Leishmania. The low number of dogs used,
the differences in breeds and in epizootiological background, including Leishmania
strains involved, may account in part for such different results.
Martinez-Moreno et al. (1995) found 65% reduction in PBMC response to Con A
stimulation in naturally infected dogs with clinical signs of leishmaniasis. In this case, the
different lymphoproliferative assay employed could explain the different rate of response
(ÿ93%) observed in our symptomatic animals.
In conclusion, our results indicate that suppression of lymphoproliferative response is
common in dogs already at the beginning of an established leishmanial infection. This
study may provide a good model to investigate the progressive immune changes in the
natural course of canine leishmaniasis, and may be helpful for correlating such changes
with parameters relevant to disease control, such as infectivity to vectors or response to
antileishmanial drugs and vaccines.
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